Serialization software provider SEA Vision has announced the new showroom opening at its French facility, with €400k investment in a new training and software testing showroom. As the industry prepares for the introduction of the Eu (FMD), the new showroom will host technical training and give pharmaceutical manufacturers hands-on experience of the systems. SEA Vision…
Caption: Federico Finotti, Sales Area Manager Serialisation software provider SEA Vision has expanded its operations in Moscow following the signing of Russia’s track and trace law. SEA Vision, which has over 20 customers in Russia and has installed over 800 full track and trace systems globally, is expanding its presence in Russia to offer local…
The company based in Pavia company transfers a minority stake to the Marchesini Group and focuses on the new challenges of Smart Manufacturing. After more than twenty years of fruitful and consolidated collaboration, SEA Vision sells 48% of its shares to the Bologna-based company, a world leader in the design and production of packaging machines:…
Serialization software provider SEA Vision and packaging machine manufacturer Marchesini Group have collaborated to launch a new OEE data collection plug-in designed to improve efficiencies during pharmaceutical manufacturing. As pharmaceutical manufacturers across the globe prepare for new serialization requirements for the tracking and tracing of medicines in the supply chain, the new plug-in complements the…
According to new industry research, more than half (54%) of industry professionals believe that the cost of implementing serialization is the greatest hurdle to compliance. The research, conducted by serialization software provider, SEA Vision and life sciences technology firm, Zenith Technologies, highlighted that the substantial investment required to implement a serialization solution is cause for…
More than one third (40 per cent) of pharmaceutical industry professionals are not confident that they will meet serialization deadlines in the US and Europe, according to new industry research. As the FDA has announced plans to delay the active enforcement of the Drug Supply Chain Security Act (DSCSA) in the US to November 2018,…
